2-Chloroacetaldehyde-induced cerebral glutathione depletion and neurotoxicity

British Journal of Cancer

Volumn 74, Issue SUPPL. XXVII, 1996, Pages

  Sood, C ^a   O'Brien, P J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chloroethanol; Ifosfamide; P450

Indexed keywords

2 CHLOROETHANOL; 2 CYCLOHEXENONE; 4 METHYLPYRAZOLE; ACETYLCYSTEINE; ALCOHOL; CHLOROACETALDEHYDE; CYTOCHROME P450; DEXAMETHASONE; GLUTATHIONE; IFOSFAMIDE; PHENOBARBITAL; ACETALDEHYDE; ALKYLATING AGENT; CYTOCHROME P450 2E1; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DEATH; DRUG METABOLISM; ENZYME ACTIVATION; ENZYME INDUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LETHARGY; MALE; MORTALITY; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATION; PARALYSIS; PRIORITY JOURNAL; ANIMAL; ARTICLE; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; LIVER; METABOLISM; PHYSIOLOGY;

ACETALDEHYDE; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN; CYTOCHROME P-450 CYP2E1; GLUTATHIONE; IFOSFAMIDE; LIVER; MALE; MICE;

EID: 0029977119     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. ARAGON CM, ROGAN F AND AMIT Z. (1991). Dose- and time-dependent effect of an acute 2-amino-1,2,4-triazole injection on rat brain catalase activity. Biochem. Pharmacol., 42, 699-702.
2. BRADE WP, HERDRICH K AND VARINI M. (1985). Ifosfamide pharmacology, safety and therapeutic potential. Cancer Treat. Rev., 12, 1-47.
3. CAVALLETTI E, TOFANETTI O AND ZUNINO F. (1986). Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity. Cancer Lett., 32, 1-6.
4. CEDERBAUM AI AND RUBIN E. (1976). Protective effect of cysteine on the inhibition of mitochondrial functions by acetaldehyde. Biochem. Pharmacol., 25, 963-973.
5. COHEN G, SINET PM AND HEIKKILA RE. (1980). Ethanol oxidation by rat brain in vivo. Alcohol Clin. Exp. Res., 4, 366-370.
6. CORCORAN GB AND WONG BK. (1986). Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: Studies with N-acetyl-D-cysteine in mice. J. Pharmacol. Exp. Ther., 238, 54-61.
7. COX PJ. (1979). Cyclophosphamide cystitis identification of acrolein as a causative agent. Biochem. Pharmacol., 28, 2045-2049.
8. DANIEL FB, DE ANGELO AB, STOBER JA, OLSON GR AND PAGE NP. (1992). Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde and dichloroacetic acid in the male B6C3F1 mouse. Fund. Appl. Toxicol., 19, 159-168.
9. DEMASTER EG, REDFERN B, SHIROTA FN AND NAGASAWA HT. (1986). Differential inhibition of rat tissue catalase by cyanamide. Biochem. Pharmacol., 35, 2081-2085.
10. ELLMAN GL. (1959). Tissue sulfhydryl groups. Arch. Biochem. Biophys., 82, 70-77.
11. FORKERT PG, REDZA ZM, MANGOS S, PARK SS AND TAM S-P. (1994). Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration. Drug Metabol. Disp., 22, 248-253.
12. GIERON MA, BARAK LS AND ESTRADA J. (1988). Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors. J. Neuro-Oncol., 6, 29-30.
13. GOREN MP, WRIGHT RK, PRATT CB AND PELL FE. (1986). Dechloroethylation of ifosfamide and neurotoxicity. Lancet, 2, 1219-1220.
14. GRIFFITH OW AND MEISTER A. (1979). Glutathione: Interorgan translocation, turnover, and metabolism. Proc. Natl Acad. Sci. USA, 76, 5606-5610.
15. GUERRI C AND GRISOLIA S. (1980). Changes in glutathione in acute and chronic alcohol intoxication. Pharmacol. Biochem. Behav., 13, 53-61.
16. HOLMES RS, DULEY JA AND BURNELL JN. (1983). The alcohol dehydrogenase gene complex on chromosome 3 of the mouse. In Isozymes, Current Topics in Biological and Medical Research, Rattazzi MC, Scandalios JG, Whit GS (eds) pp. 155-174. Alan R Liss: New York.
17. JOHNSON MK. (1967). Metabolism of 2-chloroethanol in the rat. Biochem. Pharmacol., 16, 185-199.
18. KUPFER A, AESCHLIMANN C, WERMUTH B AND CERNY T. (1994). Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet, 343, 763-764.
19. LEWIS LD AND MEANWELL CA. (1990). Ifosfamide pharmacokinetics and neurotoxicity. Lancet, 335, 175-176.
20. LIND MJ, MARGISON JM, CERNY T, THATCHER N AND WILKINSON PM. (1989a). The comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma. Cancer Res., 49, 753-757.
21. LIND MJ, MCGOWAN AT, HADFIELD JA, THATCHER N, CROWTHER D AND FOX BW. (1989b). The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochem. Pharmacol., 38, 1835-1840.
22. MADHU C, MAZIASZ T AND KLASSEN CD. (1992). Effect of pregnenolone-16α-carbonitrile and dexamethasone on acetaminophen-induced hepatotoxicity in mice. Toxicol. Appl. Pharmacol., 115, 191-198.
23. MASUDA Y AND NAKAYANIA N. (1982). Protective effect of diethyldithiocarbamate and carbon disulfide on experimental liver damage produced by various hepatotoxic agent. Biochem. Pharmacol., 31, 2713-2725.
24. MASUKAWA T, SAI MIDORI AND TOCHINO Y. (1989). Methods for depleting brain glutathione. Life Sciences, 44, 417-424.
25. REED DJ, BABSON JR, BEATTY PW, BRODIE AE, ELLIS WW AND POTTER DW. (1980). High performance liquid chromatography analysis of nanomoles levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal. Biochem., 106, 55-62.
26. SOOD C AND O'BRIEN PJ. (1993). Molecular mechanisms of 2-chloroacetaldehyde induced cytotoxicity in isolated rat hepatocytes. Biochem. Pharmacol. 46, 1621-1626.
27. SOOD C AND O'BRIEN PJ. (1994). Chloroacetaldehyde induced hepatocyte cytotoxicity: Mechanisms for cytoprotection. Biochem. Pharmacol., 48, 1025-1032.
28. SOOD C AND O'BRIEN PJ. (1996). The involvement of cytochrome P4502E1 in 2-chloroacetaldehyde-induced hepatocyte cytotoxicity. Cancer. Res. (submitted).
29. VAN DYKK JJ, VAN DER MERWE AM AND FALKSON G. (1972). Unexpected toxicity in patients treated with iphosphamide. Cancer Res., 32, 921-924.
30. WAINER IW, DUCHARME J, GRANVIL CP AND TRUDEAU M. (1994). Ifosfamide stereoselective dechlorethylation and neurotoxicity. Lancet, 343, 982-983.
31. WALKER D, FLINOIS JP, MONKMAN SC, BELOC C, BODDY AV, CHOLERTON S, DALY AK, LIND MJ, PEARSON ADJ, BEAUNE PH AND IDLE JR. (1994). Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide. Biochem. Pharmacol., 47, 1157-1163.
32. WARNER M AND GUSTAFSSON J-A. (1994). Effect of ethanol on cytochrome P450 in the rat brain. Proc. Natl Acad. Sci. USA, 91, 1019-1023.
33. WEBER GF AND WAXMAN DJ. (1993). Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes. Biochem. Pharmacol., 45, 1685-1694.